Evidence reviewed: 8 November 2026. Chlamydia and gonorrhea are common bacterial sexually transmitted infections (STIs) that frequently cause no symptoms. Without timely detection and treatment, they can lead to pelvic inflammatory disease (PID), infertility, ectopic pregnancy, epididymitis and other complications. They can infect the genitals, rectum and throat, so testing must match the sites of sexual exposure. This article corrects outdated antibiotic doses and follows the CDC STI treatment guidelines [1,2].
What causes these infections?
Chlamydia is caused by Chlamydia trachomatis, an obligate intracellular bacterium. Gonorrhea is caused by Neisseria gonorrhoeae, a bacterium capable of infecting mucosal surfaces. Transmission may occur through vaginal, anal or oral sex. Untreated infections can be transmitted during birth, causing neonatal eye or other infections. Anyone with an STI can acquire another; a positive test for one does not rule out the other [1,2].
The bacteria differ in biology and antibiotic susceptibility. Treatment must be pathogen-specific: doxycycline is a preferred treatment for uncomplicated chlamydia in nonpregnant adults, but it is not an adequate stand-alone treatment for gonorrhea. Ceftriaxone treats gonorrhea, while additional chlamydia treatment is indicated if that infection has not been excluded [1,2].
Chlamydia versus gonorrhea: symptoms
| Clinical feature | Chlamydia | Gonorrhea |
|---|---|---|
| No symptoms | Very common | Common, depending on infection site |
| Urethritis | Burning urination; clear, mucoid or other discharge | Burning urination; often purulent discharge, but appearance is not diagnostic |
| Cervicitis | Discharge, bleeding after sex or between periods | Similar features; may be asymptomatic |
| Rectal infection | Often silent; sometimes discomfort, discharge or bleeding | Often silent; sometimes discharge, tenesmus or pain |
| Pharyngeal infection | Frequently asymptomatic | Frequently asymptomatic |
Symptoms alone cannot distinguish the infections reliably. A person with genital discharge, dysuria or pelvic pain needs examination and appropriate testing, not a diagnosis based solely on the color of discharge. Other causes include urinary tract infection, vaginitis, Mycoplasma genitalium and noninfectious irritation [1,2].
Complications and emergency warning signs
Infection ascending from the cervix can cause PID, which may lead to long-term pelvic pain, tubal infertility and ectopic pregnancy. Lower abdominal or pelvic pain, fever, pain during sex, or bleeding may warrant prompt evaluation for PID or other serious conditions; treatment should not wait for advanced imaging when clinical PID is suspected. Testicular pain and swelling may indicate epididymitis, but acute severe testicular pain also requires emergency assessment to exclude torsion.
Gonorrhea can occasionally disseminate, causing joint pain, tendon inflammation or a characteristic skin rash. Purulent eye infection from gonorrhea may threaten vision and requires urgent specialist care; topical eye drops alone are not appropriate treatment for gonococcal conjunctivitis. Pregnancy can change diagnostic and treatment priorities [2].
How are chlamydia and gonorrhea diagnosed?
The preferred diagnostic method for most sites is a nucleic acid amplification test (NAAT). Specimens include vaginal swabs, first-catch urine and rectal or pharyngeal swabs as indicated by exposures and validated tests. Self-collected vaginal swabs can be an effective, accessible option. A genital urine test does not automatically detect a separate throat or rectal infection [1,2].
In symptomatic male urethritis, microscopy can provide rapid supporting evidence for gonorrhea where qualified staff and equipment are available, but it is not a universal replacement for NAAT. Culture with antimicrobial susceptibility testing is particularly important if gonorrhea treatment failure is suspected, because NAAT alone cannot routinely establish which antibiotics remain effective [2].
Sexual health assessment should consider screening for HIV, syphilis and other infections. Screening recommendations vary by age, anatomy, pregnancy, sexual practices, local epidemiology and previous test results; people can benefit from testing even when completely asymptomatic [3].
Recommended treatment for chlamydia
For nonpregnant adults and adolescents with uncomplicated chlamydia, CDC guidance recommends doxycycline 100 mg orally twice daily for 7 days. Alternatives include azithromycin 1 g orally once or levofloxacin 500 mg orally daily for 7 days when appropriate; azithromycin has lower efficacy for rectal chlamydia and is not the preferred default [1]. Drug choice should account for pregnancy, allergies, adherence, other medicines and site of infection.
Pregnancy: the recommended CDC regimen is azithromycin 1 g orally once. Amoxicillin 500 mg orally three times daily for 7 days is an alternative. Pregnant patients require a test of cure with NAAT approximately four weeks after completing treatment and should be retested around three months afterward [1]. Do not independently substitute doxycycline during pregnancy.
Special infections such as lymphogranuloma venereum (LGV) and PID require a different treatment approach and sometimes longer courses. A routine seven-day chlamydia regimen should not be assumed sufficient for every rectal syndrome or complicated infection [1].
Recommended treatment for uncomplicated gonorrhea
The earlier article advised ceftriaxone 250 mg IM plus azithromycin 1 g as routine dual treatment. This is outdated under current CDC recommendations. For uncomplicated gonorrhea of the cervix, urethra or rectum in adults and adolescents, guidance recommends [2]:
| Situation | Recommended CDC approach |
|---|---|
| Body weight under 150 kg | Ceftriaxone 500 mg intramuscularly once |
| Body weight 150 kg or more | Ceftriaxone 1 g intramuscularly once |
| Chlamydia not excluded | Add doxycycline 100 mg orally twice daily for 7 days when appropriate in a nonpregnant patient |
Uncomplicated pharyngeal gonorrhea uses the same weight-based ceftriaxone regimen but is more difficult to eradicate; there is no comparably reliable oral substitute. A patient with severe cephalosporin allergy requires specialist input [2]. In pregnancy, clinicians use pregnancy-appropriate gonorrhea and chlamydia treatment, not doxycycline automatically.
These examples are clinician-prescribed regimens, not instructions for self-treatment. Gonococcal resistance makes unnecessary antibiotic exposure a serious public-health concern. Do not reuse leftover antibiotics or assume treatment failure can be corrected by arbitrarily increasing a dose [2].
What follow-up tests are actually needed?
Chlamydia: routine immediate test of cure is not recommended for nonpregnant people who completed an appropriate course and have no continuing symptoms. NAAT performed too soon after treatment can detect residual nonviable nucleic acid, giving a misleading result. Testing at about three months is recommended because reinfection is common. Pregnant patients do need a test of cure approximately four weeks after treatment [1].
Gonorrhea: routine test of cure is not required after recommended treatment of uncomplicated urogenital or rectal infection. In contrast, people with pharyngeal gonorrhea should return for a test of cure at 7–14 days with culture or NAAT, recognizing that a NAAT at seven days may sometimes be falsely positive. Everyone treated for gonorrhea should be retested at about three months to detect reinfection [2]. Persistent symptoms require reassessment, culture and possible susceptibility testing.
When can sex resume, and what about partners?
For chlamydia, avoid sex until seven days after a single-dose regimen or until completing the seven-day course, with symptom resolution, and until partners are appropriately treated. For gonorrhea, avoid sex for seven days after treatment and until all sexual partners are treated [1,2]. The patient’s recent sexual partners—generally those in the previous 60 days—should be notified, evaluated and treated when indicated. Expedited partner therapy can be considered where permitted by local law and policy.
Condoms and barrier methods reduce transmission risk but do not replace testing or treatment. Vaccines do not currently provide routine prevention of these two STIs. People with recurrent STIs should be offered a nonjudgmental discussion of HIV prevention, including PrEP eligibility when appropriate.
Common questions
Can I have both chlamydia and gonorrhea without symptoms?
Yes. Asymptomatic infection is common. Testing based on risk and exposure matters [1-3].
Is azithromycin plus ceftriaxone still the standard treatment for gonorrhea?
No. Routine ceftriaxone 250 mg plus azithromycin dual therapy has been replaced in CDC guidance by ceftriaxone 500 mg IM for most adults under 150 kg, with doxycycline added only when chlamydia has not been excluded [2].
Do I need another test one week after treatment?
Not routinely for uncomplicated genital chlamydia or gonorrhea. The timing differs for pharyngeal gonorrhea and chlamydia in pregnancy [1,2].
Can a throat infection occur without a sore throat?
Yes. Exposure-site screening can detect asymptomatic pharyngeal gonorrhea [2].
Why treat partners if their symptoms are absent?
Partners may have asymptomatic infection. Without evaluation and treatment, reinfection and further transmission are common [1,2].
Key takeaways
Use appropriate NAAT specimens, treat each pathogen with its current recommended regimen and arrange partner care. Chlamydia in nonpregnant adults generally calls for doxycycline for seven days; uncomplicated gonorrhea generally calls for weight-based ceftriaxone. Special rules apply in pregnancy, pharyngeal infection and suspected complications.
References
- Centers for Disease Control and Prevention. Chlamydial infections: STI treatment guidelines. Atlanta: CDC; accessed 8 Nov 2026.
- Centers for Disease Control and Prevention. Gonococcal infections among adolescents and adults: STI treatment guidelines. Atlanta: CDC; accessed 8 Nov 2026.
- Centers for Disease Control and Prevention. STI screening recommendations. Atlanta: CDC; accessed 8 Nov 2026.
Medical disclaimer: Educational content only. Diagnosis, treatment and follow-up must be individualized by a qualified healthcare professional. National STI guidelines, resistance patterns and medication access may vary. Seek urgent care for severe pelvic or testicular pain, fever with pelvic symptoms, eye infection or serious illness.
Medical & AI Disclaimer
The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.
We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.